GHA
CLBT icon

GW Henssler & Associates’s Cellebrite CLBT Stock Holding History

GW Henssler & Associates’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,938
Closed -$202K – 197
2024
Q2 		$202K Sell
16,938
-72
-0.4% -$804 0.01% 162
2024
Q1 		$188K Sell
17,010
-45
-0.3% -$459 0.01% 167
2023
Q4 		$148K Sell
17,055
-13,760
-45% -$107K 0.01% 156
2023
Q3 		$236K Buy
+30,815
New +$231K 0.02% 153

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

GW Henssler & Associates's CLBT Position: Q3 2024 in Review

GW Henssler & Associates sold out of Cellebrite (CLBT) in Q3 2024, closing a stake of 16,938 shares — an estimated $202K sold.

GW Henssler & Associates first reported a position in CLBT in Q3 2023 and held it in 4 quarters. The position peaked at $236K in Q3 2023. 164 funds tracked by Wall St. Rank hold CLBT as of Q3 2024.

  • GW Henssler & Associates reported no remaining Cellebrite position as of Q3 2024 after selling out during the quarter.
  • GW Henssler & Associates sold 16,938 Cellebrite shares in Q3 2024, an estimated $202K.
  • GW Henssler & Associates first reported a position in Cellebrite in Q3 2023 and held it in 4 quarters.
  • GW Henssler & Associates's Cellebrite position peaked at $236K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Cellebrite as of Q3 2024.

Based on GW Henssler & Associates's 13F filing for Q3 2024, filed 25 Oct 2024.